Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Clinical trial NCT05580458 · RECRUITING
Trial details
- NCT number
- NCT05580458
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2027-02-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.